Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death
Most chemotherapeutic agents, including gemcitabine, do not elicit immunogenic cell death, a phenomenon associated with the release of damage-associated molecule patterns (DAMPs). Here, the authors show that gemcitabine-treated dying cancer cells express hallmark DAMPs but their immunogenic properti...
Main Authors: | K. Hayashi, F. Nikolos, Y. C. Lee, A. Jain, E. Tsouko, H. Gao, A. Kasabyan, H. E. Leung, A. Osipov, S. Y. Jung, A. V. Kurtova, K. S. Chan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-12-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-19970-9 |
Similar Items
-
Inhibitory DAMPs in immunogenic cell death and its clinical implications
by: Kazukuni Hayashi, et al.
Published: (2021-03-01) -
Immunostimulatory therapy of frequent respiratory infections in children
by: E. M. Ovsyannikova, et al.
Published: (2015-12-01) -
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
by: Abhishek D Garg, et al.
Published: (2015-11-01) -
Immunostimulatory activity of schistosomula in mice
by: Reham A. Abdel Aleem, et al.
Published: (2018-11-01) -
ANTIVIRAL AND IMMUNOSTIMULATORY POTENTIAL OF FLUORINE CONTAINING TRIAZOLES
by: K. Naumenko, et al.
Published: (2017-09-01)